
|Articles|August 1, 2001
- Applied Clinical Trials-08-01-2001
Guest Editorial
Let's start taking "e" for granted and look instead at the features we really need in clinical technology applications.
Advertisement
Articles in this issue
over 24 years ago
Public Key Infrastructure: The Beginning of a Beautiful Friendship?over 24 years ago
Ethics, Kids, and Sexover 24 years ago
Clinical Research Training on the Webover 24 years ago
The EMEA Keeps Up-to-Dateover 24 years ago
The Virtual Organization: Is It the Future Industry Landscape?over 24 years ago
Letters to the Editorover 24 years ago
Do You "Go the Extra Mile" or Adopt a Minimalist Mindsetover 24 years ago
David Sabrittover 24 years ago
The Virtual OrganizationNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
FDA Approves UCB’s Kygevi for TK2 Deficiency Based on Multi-Study Clinical Program Demonstrating Significant Survival and Motor Gains
4
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
5






.png)



.png)



.png)
.png)
